| Patents for A61P 5 - Drugs for disorders of the endocrine system (28,908) |
|---|
| 02/24/2000 | WO2000009503A1 Integrin receptor antagonists |
| 02/24/2000 | WO2000009493A1 Enantioselective synthesis |
| 02/24/2000 | WO2000009109A2 Pipecolic acid derivatives for vision and memory disorders |
| 02/24/2000 | WO2000009086A2 Protected one-vial formulation for nucleic acid molecules, methods of making the same by in-line mixing, and related products and methods |
| 02/24/2000 | WO2000009073A2 Blood-brain barrier therapeutics |
| 02/24/2000 | DE19834931A1 Verwendung von biogenen Estrogenen zur Hormonsubstitutionstherapie Use of biogenic estrogen for hormone replacement therapy |
| 02/24/2000 | DE19834006A1 Estradiolhaltiges Pflaster zur transdermalen Applikation von Hormonen Estradiolhaltiges patch for transdermal administration of hormones |
| 02/24/2000 | CA2344520A1 Pipecolic acid derivatives for vision and memory disorders |
| 02/24/2000 | CA2340418A1 Blood-brain barrier therapeutics |
| 02/24/2000 | CA2339405A1 Extracellular adhesive proteins, exadh1 and exadh2 |
| 02/24/2000 | CA2338878A1 Integrin receptor antagonists |
| 02/23/2000 | EP0980874A1 Process for production of insulin precursors having correctly linked cystein bridges |
| 02/23/2000 | EP0980386A2 Estrogen receptor crystals and ligands |
| 02/23/2000 | EP0980369A1 Sulfonamides for treatment of endothelin-mediated disorders |
| 02/23/2000 | CN1049659C Corticotropin releasing factor antagonists |
| 02/22/2000 | US6028223 An integrin antagonists treating bone disorder, periodontal disease, osteoporosis, humoral hypercalcemia of malignancy, paget's disease, tumor angiogenesis, diabetic retinopathy, arthritis, smooth muscle cell migration and restenosis |
| 02/22/2000 | US6027919 BMP-12 and BMP-13 proteins and DNA encoding them |
| 02/22/2000 | US6027749 Pharmaceutical combined preparation, kit and method for hormonal contraception |
| 02/22/2000 | CA2004532C Peptide derivatives |
| 02/21/2000 | CA2420425A1 Growth hormone secretagogues |
| 02/17/2000 | WO2000008001A1 Substituted isoxazole as estrogen receptor modulators |
| 02/17/2000 | WO2000007996A2 Pyrazoles as estrogen receptor modulators |
| 02/17/2000 | WO2000007979A2 Compounds and compositions for delivering active agents |
| 02/17/2000 | WO2000007972A1 Glucocorticoid and thyroid hormone receptor ligands for the treatment of metabolic disorders |
| 02/17/2000 | WO2000007590A1 INDOLE sPLA2 INHIBITORS |
| 02/17/2000 | CA2339194A1 Glucocorticoid and thyroid hormone receptor ligands for the treatment of metabolic disorders |
| 02/17/2000 | CA2339086A1 Dna replication- and repair-associated proteins |
| 02/17/2000 | CA2338855A1 Indole spla2 inhibitors |
| 02/16/2000 | EP0979227A1 4,1-benzoxazepines, their analogues, and their use as somatostatin agonists |
| 02/16/2000 | EP0979072A1 Transdermal device for the delivery of testosterone |
| 02/16/2000 | CN1244870A Tissue specific expression of retinoblastoma protein |
| 02/16/2000 | CN1244863A Novel benzopyran derivatives |
| 02/10/2000 | WO2000006730A2 Human cytoskeletal proteins |
| 02/10/2000 | WO2000006705A2 Genetically modified cd34-negative adherently growing stem cells and their use in gene therapy |
| 02/10/2000 | WO2000006698A1 98 human secreted proteins |
| 02/10/2000 | WO2000006601A1 Isoforms of human calcium sensing receptor |
| 02/10/2000 | WO2000006558A1 Antidiabetic piperazine derivatives, processes for their preparation and compositions containing them |
| 02/10/2000 | WO2000006534A1 Compounds and compositions for delivering active agents |
| 02/10/2000 | WO2000006185A2 Methods of using lanreotide, a somatostatin analogue |
| 02/10/2000 | WO2000006184A1 Pulmonary delivery of active agents |
| 02/10/2000 | WO2000006175A1 Use of biogenic estrogen sulfamates for hormone replacement therapy |
| 02/10/2000 | WO2000006167A1 Tricyclic compounds |
| 02/10/2000 | WO2000006137A2 Glucocorticoid-selective anti-inflammatory agents |
| 02/10/2000 | WO2000006130A1 Estradiol-containing patch for transdermal administration of hormones |
| 02/10/2000 | WO2000006032A1 Ultrasonic enhancement of drug injection |
| 02/10/2000 | CA2339301A1 Hdpbo81 nucleic acids and polypeptides |
| 02/10/2000 | CA2338861A1 Estradiol-containing patch for transdermal administration of hormones |
| 02/10/2000 | CA2338694A1 Antidiabetic piperazine derivatives, processes for their preparation and compositions containing them |
| 02/10/2000 | CA2338558A1 Use of biogenic estrogen sulfamates for hormone replacement therapy |
| 02/10/2000 | CA2338396A1 Ultrasonic enhancement of drug injection |
| 02/10/2000 | CA2338298A1 Tricyclic compounds |
| 02/10/2000 | CA2336543A1 Isoforms of human calcium sensing receptor |
| 02/10/2000 | CA2335656A1 Human cytoskeletal proteins |
| 02/10/2000 | CA2335654A1 Methods of using a somatostatin analogue |
| 02/09/2000 | EP0978517A2 Triazolopurines, process for their preparation and their use as medicaments |
| 02/09/2000 | CN1244193A Novel amide derivatives and medicinal compositions thereof |
| 02/09/2000 | CN1049214C Phenylimidazolidines, process for their preparation, their use as medicament and pharmaceutical compositions containing them. |
| 02/08/2000 | US6022978 Benzimidazole derivatives |
| 02/08/2000 | US6022850 Use of hemoglobin in the treatment of stroke |
| 02/06/2000 | CA2279747A1 Estrogen agonists/antagonists |
| 02/03/2000 | WO2000005370A1 Orphan cytokine receptor |
| 02/03/2000 | WO2000004880A1 A wet granulation method for preparing a stable pharmaceutical formulation |
| 02/03/2000 | WO1999054459A8 Nucleic acid molecules with novel chemical compositions capable of modulating gene expression |
| 02/03/2000 | WO1998055483A9 PYRROLO[2,1,5-cd]INDOLIZINE DERIVATIVES USEFUL IN THE PREVENTION OR TREATMENT OF ESTROGEN RELATED DISEASES OR SYNDROMES |
| 02/03/2000 | CA2334042A1 Orphan cytokine receptor |
| 02/02/2000 | EP0975629A1 Treatment or prophylaxis of prostatic cancer and benign prostatic hyperplasia with selective estrogen receptor modulators |
| 02/02/2000 | EP0975589A2 Dialkyl ureas as calcitonin mimetics |
| 02/02/2000 | EP0975356A1 Pulsatile delivery of leptin receptor ligands |
| 02/02/2000 | EP0975348A1 Stabilized tibolone compositions |
| 02/02/2000 | EP0881891A4 Male contraceptive implant |
| 02/02/2000 | EP0397834B1 Method for identifying active domains and amino acid residues in polypeptides and hormone variants |
| 02/01/2000 | US6020513 Dihydronaphthalene and naphthalene compounds, intermediates, formulations, and methods |
| 02/01/2000 | US6020356 Pharmaceutical composition for the treatment of autoimmune diseases |
| 02/01/2000 | US6020328 20-keto-11β-arylsteroids and their derivatives having agonist or antagonist hormonal properties |
| 02/01/2000 | US6019968 Dispersible antibody compositions and methods for their preparation and use |
| 01/27/2000 | WO2000004013A1 Antagonists of gonadotropin releasing hormone |
| 01/27/2000 | WO2000003979A1 Benzocycloheptenes, method for the production thereof, pharmaceutical preparations containing these compounds, and their use for producing medicaments |
| 01/27/2000 | WO2000003742A2 Solid oral dosage form comprising a combination of metformin and glibenclamide |
| 01/27/2000 | DE19833476A1 New genetically modified, adherently growing CD34-negative stem cells for transfer of gene therapy constructs for treatment of immunodeficiency and metabolic disorders |
| 01/27/2000 | CA2337407A1 Antagonists of gonadotropin releasing hormone |
| 01/26/2000 | EP0974356A1 Tablets comprising a combination of metformin and glibenclamide |
| 01/26/2000 | EP0973790A1 Estra-5(10),7-dienes with estrogenic activity |
| 01/26/2000 | EP0973730A1 Calcilytic compounds |
| 01/25/2000 | US6017908 3-EPI vitamin D2 compounds and uses thereof |
| 01/20/2000 | WO2000002881A2 Use of cysteine derivatives for preparing a medicine for treating pathologies resulting from the formation of heterotrimeric g protein |
| 01/20/2000 | WO2000002558A1 Use of prenyltransferase inhibitors for preparing a medicine for treating pathologies resulting from heterotrimeric g protein membrane fixation |
| 01/20/2000 | WO2000002540A1 Plaster which contains steroids, and a method for the production and use thereof |
| 01/20/2000 | DE19833786A1 New diphenyl-benzocycloheptene derivatives, are tissue-selective estrogens and antiestrogens useful e.g. for treating osteoporosis or hormone-dependent tumors or in hormone replacement therapy |
| 01/20/2000 | CA2337261A1 Use of prenyltransferase inhibitors for preparing a medicine for treating pathologies resulting from heterotrimeric g protein membrane fixation |
| 01/19/2000 | EP0972769A1 Novel amide derivatives and medicinal compositions thereof |
| 01/19/2000 | EP0972525A1 Preventives and remedies for hyperphosphatemia |
| 01/18/2000 | CA2005420C Competitive gonadoliberin antagonists |
| 01/18/2000 | CA2001124C Treatment of hypertension |
| 01/18/2000 | CA2001123C Treatment of osteoporosis |
| 01/13/2000 | WO2000001726A1 Compounds with growth hormone releasing properties |
| 01/13/2000 | DE19830651A1 Steroidhaltiges Pflaster, Verfahren zu seiner Herstellung und Verwendung Steroid-containing patch, process for its preparation and use |
| 01/12/2000 | EP0970695A1 Methods for increasing levels of acetylcholine |
| 01/12/2000 | EP0970112A2 Novel human cytokine/steroid receptor protein |
| 01/12/2000 | EP0970105A1 Process for preparing carboxamido-4-azasteroids |
| 01/12/2000 | EP0970104A2 Steroid sulfamates, method for the production and use thereof |